docour 2015 Annual Report
download 
Report Transcription
our 2015 Annual Report
Dear Friends, Support from you and others dedicated to our sight-saving mission made 2015 a great year for Glaucoma Research Foundation. Our commitment to a cure, research innovation, education and better treatments for glaucoma patients has never been stronger. Together we can truly make a positive difference in the lives of those living with glaucoma, by renewing our pledge to speed GRF Council A national leadership council of glaucoma specialists dedicated to improving access to educational materials for all glaucoma patients. Rohit Krishna, MD Chair, GRF Council Charles McMahon, MD (Mountain Regional Councilor) Carl Migliazzo, MD (Central Regional Councilor) GRF Councilors Stuart F. Ball, MD Robert J. Barnes, MD Michael S. Berlin, MD Steven V.L. Brown, MD, FACS Dean Carlson, MD John S. Cohen, MD (Midwest Regional Councilor) Randy Craven, MD Robert J. Derick, MD Monte Dirks, MD Amish Doshi, MD Doreen Fazio, MD Robert Feldman, MD (Southwest Regional Councilor) Gloria P. Fleming, MD David Gilbert, MD Linda Greff, MD Agnes Huang, MD Dan Jewelewicz, MD Martin B. Kaback, MD L. Jay Katz, MD (Northeast Regional Councilor) Anup Khatana, MD Douglas Kohl, MD Michael S. Korey, MD Linda Lawrence, MD Richard Lehrer, MD the cure and by helping those seeking information and resources to better understand this disease. Thank you for your ongoing partnership — we are now closer than ever to new glaucoma treatments and ultimately a cure. Thomas M. Brunner President and CEO Steve Litinsky, MD (Southeast Regional Councilor) Anne Miller, MD Kevin Miller, MD our Johann Ohly, MD David J. Palmer, MD Cindy Penzler, MD Andrew Prince, MD a future free from glaucoma. Andrew Rabinowitz, MD George Reiss, MD Keith Sanford, MD Michael Sakamoto, MD (Western Regional Councilor) Sonja W. Schluter, MD, MPH Bradley Schuster, MD (Mountain Regional Councilor) Arthur L. Schwartz, MD Gail F. Schwartz, MD VISION our FOCUS finding a cure. My Le Shaw, MD Rajesh Shetty, MD Charles Eric Shrader, MD Oluwatosin Smith, MD (Southwest Regional Councilor) Michael Stiles, MD Thomas Tayeri, MD Mark Werner, MD Ruth Williams, MD (Midwest Regional Councilor) Jeffrey Zink, MD 251 Post Street, Suite 600, San Francisco, CA 94108 – (415) 968-3162 – www.glaucoma.org 2015 ANNUAL REPORT Andrew G. Iwach, MD Chair, Board of Directors Dear Friends, Support from you and others dedicated to our sight-saving mission made 2015 a great year for Glaucoma Research Foundation. Our commitment to a cure, research innovation, education and better treatments for glaucoma patients has never been stronger. Together we can truly make a positive difference in the lives of those living with glaucoma, by renewing our pledge to speed GRF Council A national leadership council of glaucoma specialists dedicated to improving access to educational materials for all glaucoma patients. Rohit Krishna, MD Chair, GRF Council Charles McMahon, MD (Mountain Regional Councilor) Carl Migliazzo, MD (Central Regional Councilor) GRF Councilors Stuart F. Ball, MD Robert J. Barnes, MD Michael S. Berlin, MD Steven V.L. Brown, MD, FACS Dean Carlson, MD John S. Cohen, MD (Midwest Regional Councilor) Randy Craven, MD Robert J. Derick, MD Monte Dirks, MD Amish Doshi, MD Doreen Fazio, MD Robert Feldman, MD (Southwest Regional Councilor) Gloria P. Fleming, MD David Gilbert, MD Linda Greff, MD Agnes Huang, MD Dan Jewelewicz, MD Martin B. Kaback, MD L. Jay Katz, MD (Northeast Regional Councilor) Anup Khatana, MD Douglas Kohl, MD Michael S. Korey, MD Linda Lawrence, MD Richard Lehrer, MD the cure and by helping those seeking information and resources to better understand this disease. Thank you for your ongoing partnership — we are now closer than ever to new glaucoma treatments and ultimately a cure. Thomas M. Brunner President and CEO Steve Litinsky, MD (Southeast Regional Councilor) Anne Miller, MD Kevin Miller, MD our Johann Ohly, MD David J. Palmer, MD Cindy Penzler, MD Andrew Prince, MD a future free from glaucoma. Andrew Rabinowitz, MD George Reiss, MD Keith Sanford, MD Michael Sakamoto, MD (Western Regional Councilor) Sonja W. Schluter, MD, MPH Bradley Schuster, MD (Mountain Regional Councilor) Arthur L. Schwartz, MD Gail F. Schwartz, MD VISION our FOCUS finding a cure. My Le Shaw, MD Rajesh Shetty, MD Charles Eric Shrader, MD Oluwatosin Smith, MD (Southwest Regional Councilor) Michael Stiles, MD Thomas Tayeri, MD Mark Werner, MD Ruth Williams, MD (Midwest Regional Councilor) Jeffrey Zink, MD 251 Post Street, Suite 600, San Francisco, CA 94108 – (415) 968-3162 – www.glaucoma.org 2015 ANNUAL REPORT Andrew G. Iwach, MD Chair, Board of Directors 2015 working TOGETHER SHAFFER GRANTS accelerating the pace of discovery. we can find the cure. Board of Directors Glaucoma Research Foundation provides one- leadership gifts from The Frank Stein and year, $40,000 grants for creative pilot research Paul S. May Grants for Innovative Glaucoma projects allowing investigators to explore new Research, The Alcon Foundation, the Dr. Henry and promising ideas in glaucoma. The 2015 A. Sutro Family Grant for Research, Dr. James research grants were made possible through and Elizabeth Wise, and The Dr. Miriam Yelsky generous philanthropic support including Memorial Research Grant. Board Chair Andrew G. Iwach, MD Glaucoma Center of San Francisco San Francisco, CA Alfredo Dubra, PhD Associate Professor of Ophthalmology and Biophysics Department of Ophthalmology, The Eye Institute Medical College of Wisconsin Milwaukee, Wisconsin Donald L. Budenz, MD, MPH Paul L. Kaufman, MD Richard T. Libby, PhD Paloma Liton, PhD University of North Carolina Chapel Hill, NC University of Wisconsin School of Medicine and Public Health Madison, Wisconsin University of Rochester Medical School Rochester, New York Duke University Eye Center Durham, North Carolina Jeffrey L. Goldberg, MD, PhD Andrew Huberman, PhD Professor and Chair of Ophthalmology The Byers Eye Institute at Stanford Palo Alto, California Assistant Professor of Neurosciences, Biology and Ophthalmology University of California San Diego San Diego, California President and CEO Vivek Srinivasan, PhD Thomas M. Brunner Glaucoma Research Foundation San Francisco, CA Assistant Professor of Biomedical Engineering University of California Davis Davis, California Vice Chair Robert L. Stamper, MD University of California San Francisco, CA Secretary Rick Halprin, CPA Alcon Laboratories, Inc. Fort Worth, TX the CATALYST Treasurer FOR A CURE Frederick H. Brinkmann Director, Information Technology (Retired) Palo Alto, CA speeding a cure for glaucoma. Directors Timothy J. Dwyer Private Investor Woodside, CA Lyne Racette, PhD Matthew A. Smith, PhD Shandiz Tehrani, MD, PhD Gülgün Tezel, MD Indiana University Indianapolis, Indiana University of Pittsburgh Pittsburgh, Pennsylvania Oregon Health & Science University Portland, Oregon Columbia University New York, New York The Catalyst for a Cure (CFC) Biomarker Initiative brings together four research laboratories to find new and sensitive measures for detecting and treating glaucoma. The team is working collaboratively to develop innovative tools that will enable eye doctors to detect glaucoma at its earliest stages and indicate which patients are most at risk for vision loss. This year the CFC team identified eight possible new biomarkers for glaucoma. With the team’s expertise in neurobiology and optical engineering, they are designing and building specialized equipment to provide imaging of the earliest changes in the eye that may indicate glaucoma. This important work promises to transform glaucoma care and preserve vision for countless patients worldwide. Learn more at glaucoma.org/catalyst Visit glaucoma.org/grants to learn more about our 2015 research grants. 3 4 Adrienne L. Graves, PhD Independent Director San Francisco, CA Yehia Hashad, MD Allergan, Inc. Irvine, CA John Hetherington, Jr., MD University of California San Francisco, CA H. Dunbar Hoskins, Jr., MD American Academy of Ophthalmology (Retired) San Francisco, CA Linda C. Linck Delta Gamma Foundation Lafayette, CA Dennis E. Singleton Spieker Partners Menlo Park, CA Monica L. Vetter, PhD University of Utah Salt Lake City, UT Martin B. Wax, MD PanOptica, Inc. Bernardsville, NJ Ruth D. Williams, MD Wheaton Eye Clinic Wheaton, IL Charles Wilmoth Wells Fargo Advisors, LLC San Francisco, CA Founder Robert N. Shaffer, MD (1912–2007) Honorary Advisory Board F.T. Barr Afex International, Inc. Houston, TX June Behrendt Otto The Edward J. Daly Foundation San Francisco, CA Sarah Brown San Francisco, CA Robert Drabkin Los Angeles, CA Steven Kirsch San Jose, CA Roger McGuinn Windemere, FL Robert C. Nevins Lafayette, CA David E.I. Pyott Irvine, CA Cary R. Rayment Alcon, Inc. (Retired) Ft. Worth, TX Mona Zander The Mona and Ed Zander Family Foundation Carmel, CA Professional Staff Thomas M. Brunner President and CEO Catalina San Agustin Director of Operations Michelle Davidson Development Coordinator Nancy Graydon Executive Director of Development Aileen Trieu Associate Director of Development Bonnie MacLeod Development Assistant Andrew L. Jackson Director of Communications Christie D’Angelo Assistant Director, Events and Volunteer Management 13 2015 working TOGETHER SHAFFER GRANTS accelerating the pace of discovery. we can find the cure. Board of Directors Glaucoma Research Foundation provides one- leadership gifts from The Frank Stein and year, $40,000 grants for creative pilot research Paul S. May Grants for Innovative Glaucoma projects allowing investigators to explore new Research, The Alcon Foundation, the Dr. Henry and promising ideas in glaucoma. The 2015 A. Sutro Family Grant for Research, Dr. James research grants were made possible through and Elizabeth Wise, and The Dr. Miriam Yelsky generous philanthropic support including Memorial Research Grant. Board Chair Andrew G. Iwach, MD Glaucoma Center of San Francisco San Francisco, CA Alfredo Dubra, PhD Associate Professor of Ophthalmology and Biophysics Department of Ophthalmology, The Eye Institute Medical College of Wisconsin Milwaukee, Wisconsin Donald L. Budenz, MD, MPH University of North Carolina Chapel Hill, NC Paul L. Kaufman, MD Richard T. Libby, PhD Paloma Liton, PhD University of Wisconsin School of Medicine and Public Health Madison, Wisconsin University of Rochester Medical School Rochester, New York Duke University Eye Center Durham, North Carolina Jeffrey L. Goldberg, MD, PhD Andrew Huberman, PhD Professor and Chair of Ophthalmology The Byers Eye Institute at Stanford Palo Alto, California Assistant Professor of Neurosciences, Biology and Ophthalmology University of California San Diego San Diego, California President and CEO Vivek Srinivasan, PhD Thomas M. Brunner Glaucoma Research Foundation San Francisco, CA Assistant Professor of Biomedical Engineering University of California Davis Davis, California Vice Chair Robert L. Stamper, MD University of California San Francisco, CA Secretary Rick Halprin, CPA Alcon Laboratories, Inc. Fort Worth, TX the CATALYST Treasurer FOR A CURE Frederick H. Brinkmann Director, Information Technology (Retired) Palo Alto, CA speeding a cure for glaucoma. Directors Timothy J. Dwyer Private Investor Woodside, CA Lyne Racette, PhD Indiana University Indianapolis, Indiana Matthew A. Smith, PhD University of Pittsburgh Pittsburgh, Pennsylvania Shandiz Tehrani, MD, PhD Gülgün Tezel, MD Oregon Health & Science University Portland, Oregon Columbia University New York, New York The Catalyst for a Cure (CFC) Biomarker Initiative brings together four research laboratories to find new and sensitive measures for detecting and treating glaucoma. The team is working collaboratively to develop innovative tools that will enable eye doctors to detect glaucoma at its earliest stages and indicate which patients are most at risk for vision loss. This year the CFC team identified eight possible new biomarkers for glaucoma. With the team’s expertise in neurobiology and optical engineering, they are designing and building specialized equipment to provide imaging of the earliest changes in the eye that may indicate glaucoma. This important work promises to transform glaucoma care and preserve vision for countless patients worldwide. Learn more at glaucoma.org/catalyst Visit glaucoma.org/grants to learn more about our 2015 research grants.. 3 4 Adrienne L. Graves, PhD Independent Director San Francisco, CA Yehia Hashad, MD Allergan, Inc. Irvine, CA John Hetherington, Jr., MD University of California San Francisco, CA H. Dunbar Hoskins, Jr., MD American Academy of Ophthalmology (Retired) San Francisco, CA Linda C. Linck Delta Gamma Foundation Lafayette, CA Dennis E. Singleton Spieker Partners Menlo Park, CA Monica L. Vetter, PhD University of Utah Salt Lake City, UT Martin B. Wax, MD PanOptica, Inc. Bernardsville, NJ Ruth D. Williams, MD Wheaton Eye Clinic Wheaton, IL Charles Wilmoth Wells Fargo Advisors, LLC San Francisco, CA Founder Robert N. Shaffer, MD (1912–2007) Honorary Advisory Board F.T. Barr Afex International, Inc. Houston, TX June Behrendt Otto The Edward J. Daly Foundation San Francisco, CA Sarah Brown San Francisco, CA Robert Drabkin Los Angeles, CA Steven Kirsch San Jose, CA Roger McGuinn Windemere, FL Robert C. Nevins Lafayette, CA David E.I. Pyott Irvine, CA Cary R. Rayment Alcon, Inc. (Retired) Ft. Worth, TX Mona Zander The Mona and Ed Zander Family Foundation Carmel, CA Professional Staff Thomas M. Brunner President and CEO Catalina San Agustin Director of Operations Michelle Davidson Development Coordinator Nancy Graydon Executive Director of Development Aileen Trieu Associate Director of Development Bonnie MacLeod Development Assistant Andrew L. Jackson Director of Communications Christie D’Angelo Assistant Director, Events and Volunteer Management 13 our MISSION to prevent vision loss. At Glaucoma Research Foundation, our mission is to prevent vision loss from glaucoma by investing in innovative research, education, and support with the ultimate goal of finding a cure. Our Foundation was founded in 1978 in San Francisco by three visionary glaucoma specialists who wanted to encourage innovative research to find better ways to care for people with glaucoma — the world’s leading cause of preventable blindness. Since then we have funded successful collaborative research programs, leading the way in glaucoma research until a cure is found. SCIENTIFIC ADVISORS Ben Barres, MD, PhD Stanford University School of Medicine Balwantray Chauhan, PhD Dalhousie University, Nova Scotia George A. Cioffi, MD Columbia University College of Physicians and Surgeons Anne L. Coleman, MD, PhD Jules Stein Eye Institute Scott Fraser, PhD University of Southern California Christopher A. Girkin, MD University of Alabama at Birmingham David S. Greenfield, MD University of Miami Leonard A. Levin, MD, PhD McGill University Health Centre Steven L. Mansberger, MD, MPH Devers Eye Institute/Legacy Health Martin Raff, MD University College, London Douglas Rhee, MD Case Western Reserve University School of Medicine Joel S. Schuman, MD University of Pittsburgh School of Medicine Ernst R. Tamm, MD University of Regensburg, Germany Russell Van Gelder, MD, PhD University of Washington Monica Vetter, PhD University of Utah Martin B. Wax, MD PanOptica, Inc. Arthur J. Weber, PhD Michigan State University Janey L. Wiggs, MD, PhD Massachusetts Eye & Ear Infirmary 5 RESEARCH RESULTS 2014 grants to explore new ideas. Vikas Gulati, MD David Krizaj, PhD Yutao Liu, MD, PhD Robert W. Nickells, PhD Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE Moran Eye Institute, University of Utah, Salt Lake City, UT Medical College of Georgia, Georgia Regents University, Augusta, GA University of Wisconsin, Madison, WI Knowledge gained from this study will help guide therapy for elevated IOP associated with use of anti-VEGF drugs. This project identified new therapeutic targets for glaucoma, and developed and tested new neuroprotection treatments. This research project comprehensively characterized the exosome particles in aqueous humor, which may lead to a biomarker and therapeutic targets for glaucoma. Results of this study will impact therapeutic applications of drugs designed to limit activation of the innate immune response by providing cell-specific targeting of these drugs. Stuart J. McKinnon, MD, PhD Colm O’Brien, MD, FRCS Joshua D. Stein, MD, MS Duke University Medical Center, Durham, NC Mater Misericordiae University Hospital, Dublin, Ireland W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, MI A project to determine whether therapies can be designed to modulate the immune system to prevent vision loss and blindness in glaucoma patients. This study showed a unique molecular link between specific events and cells in the trabecular meshwork that may be a target for further investigation and drug discovery. The researchers developed a sophisticated tool that can help eye doctors predict whether a patient’s glaucoma will remain stable or get worse over time. To learn more about our research progress visit glaucoma.org/research 6 RESEARCH COLLABORATION ensuring a fresh perspective. With Catalyst for a Cure (CFC), Glaucoma Research Foundation has taken an unprecedented approach by intentionally seeking experts from both inside and outside the mainstream of glaucoma research to ensure a fresh perspective. We have a history of success with multi-year, collaborative research projects that have helped shape the direction of glaucoma research and improved patient care. Glaucoma Research Foundation’s Scientific Advisors asked the CFC team to focus on research that takes maximum advantage of their combined, diverse skills. As a result of this innovative approach, the CFC research collaborations have made significant discoveries that have changed our understanding of glaucoma and inspired other scientists around the world. 7 4% Foundations 6% Conferences 1% Corporations 3% Administration 12% Development 7% Investments 24% Education Revenue 82% Individuals 61% Research Expenses 2015 FINANCIAL REPORT financial responsibility and transparency. Total revenue for the fiscal year ended June 30, 2015 was $4 million. Through generous support from our donors, $3.3 million was committed to innovative glaucoma research and education programs. Glaucoma Research Foundation continues to have a strong balance sheet, finishing the year with a small surplus. Since 1978, we have invested more than $50 million to advance essential research and education. We receive no government funding and rely primarily on private philanthropy. Careful stewardship ensures that 85 cents of every dollar donated goes directly to research and education programs. Independent nonprofit evaluators Charity Navigator and GuideStar give us high ratings for transparency and accountability. Our audited financial reports are available on our website and we meet all twenty of the Better Business Bureau’s Standards for Charity Accountability. Thank you for your personally significant contributions and your ongoing advocacy to help speed the cure. Frederick H. Brinkmann Treasurer 8 Glaucoma Research Foundation Statement of Activities for the Year Ended June 30, 2015* Unrestricted 2015 Temporarily Permanently Restricted Restricted SUPPORT AND REVENUE Donations and bequests Special Events, net of expenses Other Income/Reductions Investment Income Change in value of charitable trusts Conference/Forum income Assets released from restrictions Total Revenue, gains, & support $1,598,282 502,199 15,358 174,141 8,591 252,857 210,698 2,762,126 $1,271,275 – – 117,529 – – (210,698) $1,178,106 EXPENSES Research Programs Education Programs Administration Fundraising Total Expenses $2,347,906 917,912 114,367 446,257 3,826,442 – – – – Change in Net Assets Net Assets, beginning of year Net Assets, end of year (1,064,316) 4,300,098 3,235,782 1,178,106 672,002 1,850,108 $42,500 – – – – – – $42,500 42,500 3,300,000 3,342,500 2014 Total Total $2,912,057 502,199 15,358 291,670 8,591 252,857 – 3,982,732 $3,331,326 456,637 5,114 1,220,624 (4,695) 287,834 – 5,296,840 $2,347,906 917,912 114,367 446,257 3,826,442 $2,545,955 716,473 139,925 498,078 3,900,431 156,290 8,272,100 8,428,390 1,396,409 6,875,691 8,272,100 Statement of Financial Position as of June 30, 2015* ASSETS CURRENT ASSETS Cash Pledges and bequests receivable Prepaid expenses Booklet inventory TOTAL CURRENT ASSETS NON-CURRENT ASSETS Pledges and bequests receivable (net of present value discount and current portion) Assets held in trust (at market value) Investments (at market value) Furniture and equipment (net of depreciation) Permanently restricted cash TOTAL NON-CURRENT ASSETS TOTAL ASSETS LIABILITIES AND NET ASSETS CURRENT LIABILITIES Accounts payable and accrued expenses Trusts, distributions payable, current portion Grants payable TOTAL CURRENT LIABILITIES NON-CURRENT LIABILITIES Liabilities to trust beneficiaries (at present value) TOTAL LIABILITIES NET ASSETS Unrestricted Temporarily restricted Permanently restricted net assets TOTAL NET ASSETS TOTAL LIABILITIES AND NET ASSETS *Audited Financial Report 2015 2014 $666,585 186,610 118,567 31,822 1,003,584 $782,122 123,335 133,993 31,458 1,070,908 108,000 – 191,947 4,959,650 33,096 3,342,500 8,635,193 $9,638,777 261,326 4,675,803 45,632 3,300,000 8,282,761 $9,353,669 50,261 25,907 1,035,000 1,111,168 47,762 26,125 885,000 958,887 99,219 1,210,387 122,682 1,081,569 3,235,782 1,850,108 3,342,500 8,428,390 $9,638,777 4,300,098 672,002 3,300,000 8,272,100 $9,353,669 9 our BOLD VISION the cure is in sight. In Appreciation We express our deepest appreciation to all of our donors. Each and every gift is essential and assists us with forwarding our important mission. Mellam Family Foundation New World Medical, Inc. Ora, Inc. Robert & Terri Cohn Family Foundation Union Bank The following is a listing of contributors of $500 or more from July 1, 2014 to June 30, 2015. Sponsors ($5,000 to $9,999) CORPORATIONS AND FOUNDATIONS Benefactors ($100,000 to $199,999) The Alcon Foundation, Inc. Founders ($50,000 to $99,999) The Edward Joseph Daly Foundation Pacesetters ($25,000 to $49,999) Allergan, Inc. The Allergan Foundation The Max & Evelyn Schacknow Foundation, Inc. Medical Research Charities Patrons ($10,000 to $24,999) Abbott Medical Optics Aerie Pharmaceuticals, Inc. Alcon Laboratories, Inc. ANA, All Nippon Airways Bausch + Lomb Canon USA, Inc. Carl Zeiss Meditec, Inc. Carol Young Brooke Foundation Colliers International Dodge & Cox DSM Biomedical Inc. Elite Island Resorts Genentech, Inc. Haag-Streit USA, Inc. Lumenis, Inc. 10 Allstate Life Insurance Company Beaver-Visitec International, Inc. CenterVue, Inc. Delta Gamma Foundation Ellex, Inc. Glaukos Corporation Heidelberg Engineering, Inc. Icare USA Imperial Hotel, Tokyo Iridex Corporation The Kahn Foundation Mobius Therapeutics, LLC Morgan Stanley matching gift from Stephanie and N. D’Arcy Roche Neighbor To Nation Nidek, Inc. Ocular Therapeutix, Inc Optovue, Inc. The Polakoff Foundation Reichert, Inc. Santen, Inc. Shire TearLab Corporation West Charitable Trust President’s Club ($1,000 to $4,999) Akorn, Inc. American Endowment Foundation AMETEK Delta Gamma, Diablo Valley Alumnae Chapter Elsewhere Advertising & Communications Envisia Therapeutics Glen Ellyn Ophthalmology Handcrafted Portraits Jessup Cellars K. Arakelian Foundation Kaur Photography Macy’s Foundation Mai Land Corporation Maryland Charity Campaign Mega Hertz Microsoft Matching Gifts Program NeoMedix Corporation Nicox, Inc. NovaBay Pharmaceuticals, Inc. Ophthalmic Mutual Insurance Company The Palace Hotel Pfund Family Foundation Rogers Group, Inc. The Charles Henry Smith Sr. Foundation Teachers Insurance and Annuity Association College Retirement Equities Fund Transcend Medical, Inc. Yellow Jacket River Guides Contributors ($500 to $999) The Arnold Foundation Breitman Family Foundation, Inc. Chevron Humankind Employee Funds Concrete Technology Corporation Disneyland Resort GE Foundation Gerber Kawasaki Wealth and Investment Management Hinomaru Limousine Co., Ltd. J. B. Kennedy School The Mandarin Oriental, San Francisco miLEAD Consulting Olivia Riegel Pharmalogic Development Inc. Pier 39 RHMM Inc. Southwest Airlines Co. thrive SF Fitness INDIVIDUALS Visionaries ($200,000+) The Paul S. May Trust Benefactors ($100,000 to $199,999) Charlot and Dennis E. Singleton Founders ($50,000 to $99,999) Wallace and Thomas M. Brunner Roberta R.W. Kameda Steve and Michele Kirsch Hazel G. Moore Estate Judith and Charles Munnerlyn, PhD Stuart Stephens Pacesetters ($25,000 to $49,999) Geraldine J. Allen Mr. and Mrs. F.T. Barr Frederick H. and Cynthia L. Brinkmann Estate of Mary Klasek Iris and Lawrence Lerner The Light Trust Estate of Jon Nichols Naomi and Robert Stamper, MD Liz Stratton The Henry A. Sutro Trust Catherine and Charles Wilmoth Dr. James and Elizabeth Wise Mona and Edward Zander Continued from page 10. Patrons ($10,000 to $24,999) Stuart Abelson, MBA Arlene Anthony Jill and Michael Chmura Germaine and Timothy Dwyer, Wendy Dwyer Memorial Margaret and Russell Garvin, CPA Frank and Joseph Gila Fund Adrienne L. Graves, PhD Nancy M. Graydon Larry and Carie Haimovitch Yehia Hashad, MD Elizabeth T. Heim Trust Ann and H. Dunbar Hoskins, Jr., MD Frances Vaughan Hunt Andrew G. Iwach, MD Ellwood H. Johnson Rose J. Lem Kathlyn McPherson Masneri and Arno P. Masneri Fund The Link Family Hiro Ogawa Lennart H. Olsson Trust Janet and Cary Rayment Sandra and Marvin Rubin, Rubin Obstgarten Family Foundation The Rhett and Xin Schiffman Charitable Fund Virginia M. Shaffer Emmett Skinner, Jr. Frank Stein Matthew Tate, PhD Sponsors ($5,000 to $9,999) Mike and Darlene Arnold Lori and H. Allen Bouch Sarah and Bill Brown Paula and Paul Chaney Alfred and Riqueza Fenaughty Barry Friedberg Estate of Leah C. Karet Charles and Jane Kusek Lawrence S. Lipkind, DDS Donna F. Mahin Angela Nomellini and Kenneth E. Olivier Deirdre Porter and Bradford Hall Paul Anthony Ridder Stephanie and N. D’Arcy Roche Randolph C. Roeder John Russell Tamara and Paul Suslov Family Trust Arthur S. Takahara Catalyst Circle ($1,000 to $4,999) Elle Abi Kenneth Abramowitz Michael Ackermann, PhD James Allen Thea Amberg Fred Amoroso Weston and Jeannette Anderson Anonymous Judy Arnold The Beach Foundation Lezlie Beam James and Virgene Beam Hugh Beckman, MD Arleen and Robert Belyea Karen Bertrand Robert F. Blitzer The Bodri Foundation of the Jewish Community Federation and Endowment Fund Richard Bondurant Tom Bradshaw Jared Brennan J.A. Brown John and Sue Brubaker Dr. Edward & Mildred Cafritz Family Foundation James and Linda Cafritz Linda and George Cioffi, MD Ranjana and Michael Clark Nobuko Saito Cleary and Gary Cleary, PharmD, PhD Scott Corning Alan S. Crandall, MD C. Seth Cunningham Anupam Dalal, MD Michael Darling Eugene de Juan, Jr., MD Nathaniel De Rothschild Seth DeAvila Victoria and Donald F. DeMuth Molly and Brett Dick Patrick W. Dwyer Carolyn Edward Michael and Tracey Elfstrom Dr. Frank Ellsworth Peter Falzon Marilyn A. Fenneman and Alex Forrester Anthony R. Fisher, PhD Ken Fitzsimmons Donna M. Freer-Stannard Mabel I. Frohriep Martin and Gwen Gans Buck Gee LaRue R. Gibson, Jr. Margaret and Joseph F. Govednik Gary Greenberg Carol M. Hall Sharlene and Alfred Hall, PharmD Louise and Rick Halprin, CPA Tracy Hammond Robert T. Harker Gena Harper, Carla J. Koren and Morgan Stanley Marjorie D. Hart Paul Heiman Susan and John Hetherington, Jr., MD Eve Higginbotham, SM, MD Andrew Huberman, PhD Rebecca Hussain Takashi Iizuka Manraj Johl Robert Karp Guy M. Kezirian, MD Jean D. Kliewer David and Janet Kline Andrew J. Kujawa Patricia Lee Paul P. Lee, MD, JD Linda and Donald Linck, DDS Jaci and Richard L. Lindstrrom, MD Marsha Link, PhD and William J. Link, PhD Jane R. Lurie Grace and George R. Marcellino, PhD James Mazzo Rev. and Mrs. Alexander McLachlan Elizabeth B. and Carl V. Migliazzo, MD Lawrence and Liz Morris Seymour and Pearl Moskowitz Sandra Moss Geeta Narendra Ahya Debbie and Robert C. Nevins Marjorie A. Nevitt Vincent E. O’Brien Charlotte L. Petty Elda and Richard Phillips Robert L. Pondelicek Hardy and Ellie Prentice Carol and George Rogers Lillian Rosenthal Thomas Samuelson, MD Sonja Schluter, MD David and Rosy Schwartz Karen Schwartz and Sam Shelanski Hemant Shah Patrick J. Shuler Saul Siemaska Mary R. Skuce Margaret Slattery Laine and Carl Smith Stephen E. Smith Jeffrey and Nancy Soluri Michael Speyer Richard Steegstra Nancy L. Stegens Tania W. Stepanian Anne Stoddard Joyce Suchsland Shigemi Sugiki, MD, FACS Catherine and Richard Tate Marian and Julius Tills Endowment Fund of the Dallas Jewish Community Foundation Dr. and Mrs. Thomas G. Todaro Elias Vamvakas Carolyn and Matthew Vanderberg Rebecca and Steven Vilendrer Barbara and Robert Voss Vincent A. Wallace Lisa and Marty Wax, MD Kerry Welsh Jane Weston, MD and Jan Horn, MD Dr. and Mrs. George M. Weston, In Loving Memory of Daniel Scott Weston John and Cynthia Wied Mike Winn Bruce and Katrina Woodske Ratna K. Yadla, MD Jackie and Phillip Young Cheryl and Thomas Young Alan Zafran Contributors ($500 to $999) Robert Adams Tony Altig Betty J. Annis 11 Continued from page 11. Michele Barrett J. Bronwyn Bateman, MD and Douglas Hershey, MD Tatyana Beldock Michael Boyd David Brandt Rosie Brewster-Crowder Diana and James Brooks Mark Brown Kevin Butt William F. Cael Michelle Carpenter, JD Joan Carroll Julie Chase Julie and John S. Cohen, MD James E. Coleman, Jr. Craig Corbitt and Nancy Stoltz Ellis Courte Ken J. Damozonio Christina D’Angelo Henry Davis Diana Leis Delker Edith Derbyshire Robert J. Derick, MD Jeffrey J. Drzazgowski Kimberly Eckstein William Edlund Teresa Ann Ellis John F. Farina Robert D. Fechtner, MD Steven and Debra Fendrich Dan Finkle Elizabeth Flagg Anjai Gandhi Carolyn R. Gregory William Gregory Lorraine Gullett Craig Palmer and Allen Habel Mary Hackenbracht Linda Hambley Stephanie Handler Karen Harris The Hart 1998 Charitable Remainder Unitrust Paul Harvey, Jr. Doug and Katherine Hayes Patrick Healy, MPH Susan Hilton Patricia Holst Les and Eleanore Holve Don Hood, PhD Dan Joraanstad and Robert Hermann Jerrold Keilson Reginald and Grace King Bill and Carolyn Kolzow 12 Michael and Ina Korek Foundation Trust Edward Lee Diane Lee Edna Lewis Laura and Steven M. Litinsky, MD Robert and Delores Lyons Kelley MacDonald and R. Thomas Martell, Jr. Peter Marino Isao S. Matsuura Estate of Carol S. McCulle Thomas and Jean Meeks Elsie A. Michael Ray and Becky Middleton Dorothy M. Miles Richard P. Mills, MD Laurel B. and Steven R. Miranda Earl L. and Eleanor J. Mitchell Thomas Mitro Stewart Munnerlyn Christopher B. Nash Howard Nodell T. Michael Nork, MD Dona and Gary D. Novack, PhD Judy F. Oliphant John and Alice Osterman Scott Pastor, MD Hans Peter Pfleger Nancy and Charles Philipp Terri Pickering, MD David Plummer Sam and Denise Polakoff Carol L. Rainey Andrew Rockefeller Jill Rosenberg Susan Ryu, MD and Michael Gaynon, MD Ronald Sanders James Michael Scarborough Sheila Schlee Kathryn Schloessman Charles L. Schmidt Todd Scott John M. Segal Marjorie and Jay Segal Hiroaki Serizawa, PhD Grace Seto James Shaleuly Anthony Shih Elizabeth Singleton Michael Snell Dorris and Bill Stewart Martha C. Stisser Craig Sundstrom Joyce and John Thomas Kathy M. Thomas R. Douglas Townsend Samuel Urcis and Marion Zola Mark Vanderberg Margrit Vanderryn David Verzello and Patrick Cameron Hazel H. Wada Margo Walker Clayton Waugh Brian A. Welcome, MD Robert Widi ADDITIONAL CONTRIBUTORS We are grateful to the more than 3,000 donors who have contributed this year to forward our mission. Thank you for your steadfast support. THE BLANCHE MATTHIAS SOCIETY The Blanche Matthias Society recognizes those individuals who have included Glaucoma Research Foundation in their estate plans. We are grateful to the following individuals that have notified us of their intent to us as a beneficiary in their wills, trusts, or other investment vehicles. Steven Aberblatt MariLynn Bagienski Schuyler and Susie Bailey Andrew Balaban Gerald Beresniewicz Barbara J. Bethune Frances O. Blair Wallace and Thomas M. Brunner Barbara R. Conway Donald J. Digby, MD, FACS, FAAO Robert J. Drabkin Sharon Entwistle Arla Escontrias John Filozof Marina Flores Carol Gasiorek E. Yvonne and William O. Geisert Gloria Greenlee Carie and Larry Haimovitch Ron Strickland and Christine Hartmann Ruth M. Henning Andrew G. Iwach, MD Esther Jones Shirley Kalgaard Arlyne Krum Nancy Lam Laurence Lande Sharon Leahy Donald Loesch Charles K. Long Jane R. Lurie Richard Malm Dolores Nieves Mr. and Mrs. Jack A Nunes Marnay O’Neal Betty Riess Barbara J. Ritzenthaler Cheryle Rost Mary J. Schaaf Judith Schnorf Marianne Seidenberger Emmett Skinner, Jr. Sara Marie Smith Elizabeth Snyder Mary Ann Spicer Burton Spiller Micheline and William Steckman William Steckowich Frank Stein Brian P. Vaughan Dr. Lars M. Vistnes and Mrs. Carol Vistnes Mel Walker Barbara H. Wilson Craig T. Woodbury And three anonymous members For more information on the Blanche Matthias Society, visit our website at glaucoma.org/involved or contact us at 415-986-3162. This honor roll is composed of major donors who supported Glaucoma Research Foundation from July 1, 2014 to June 30, 2015. If your name has been omitted or there is an error in the listing, we ask that you notify us at 251 Post Street, Suite 600, San Francisco, CA 94108 or call 415-986-3162. 2015 working TOGETHER SHAFFER GRANTS accelerating the pace of discovery. we can find the cure. Board of Directors Glaucoma Research Foundation provides one- leadership gifts from The Frank Stein and year, $40,000 grants for creative pilot research Paul S. May Grants for Innovative Glaucoma projects allowing investigators to explore new Research, The Alcon Foundation, the Dr. Henry and promising ideas in glaucoma. The 2015 A. Sutro Family Grant for Research, Dr. James research grants were made possible through and Elizabeth Wise, and The Dr. Miriam Yelsky generous philanthropic support including Memorial Research Grant. Board Chair Andrew G. Iwach, MD Glaucoma Center of San Francisco San Francisco, CA Alfredo Dubra, PhD Associate Professor of Ophthalmology and Biophysics Department of Ophthalmology, The Eye Institute Medical College of Wisconsin Milwaukee, Wisconsin Donald L. Budenz, MD, MPH University of North Carolina Chapel Hill, NC Paul L. Kaufman, MD Richard T. Libby, PhD Paloma Liton, PhD University of Wisconsin School of Medicine and Public Health Madison, Wisconsin University of Rochester Medical School Rochester, New York Duke University Eye Center Durham, North Carolina Jeffrey L. Goldberg, MD, PhD Andrew Huberman, PhD Professor and Chair of Ophthalmology The Byers Eye Institute at Stanford Palo Alto, California Assistant Professor of Neurosciences, Biology and Ophthalmology University of California San Diego San Diego, California President and CEO Vivek Srinivasan, PhD Thomas M. Brunner Glaucoma Research Foundation San Francisco, CA Assistant Professor of Biomedical Engineering University of California Davis Davis, California Vice Chair Robert L. Stamper, MD University of California San Francisco, CA Secretary Rick Halprin, CPA Alcon Laboratories, Inc. Fort Worth, TX the CATALYST Treasurer FOR A CURE Frederick H. Brinkmann Director, Information Technology (Retired) Palo Alto, CA speeding a cure for glaucoma. Directors Timothy J. Dwyer Private Investor Woodside, CA Lyne Racette, PhD Indiana University Indianapolis, Indiana Matthew A. Smith, PhD University of Pittsburgh Pittsburgh, Pennsylvania Shandiz Tehrani, MD, PhD Gülgün Tezel, MD Oregon Health & Science University Portland, Oregon Columbia University New York, New York The Catalyst for a Cure (CFC) Biomarker Initiative brings together four research laboratories to find new and sensitive measures for detecting and treating glaucoma. The team is working collaboratively to develop innovative tools that will enable eye doctors to detect glaucoma at its earliest stages and indicate which patients are most at risk for vision loss. This year the CFC team identified eight possible new biomarkers for glaucoma. With the team’s expertise in neurobiology and optical engineering, they are designing and building specialized equipment to provide imaging of the earliest changes in the eye that may indicate glaucoma. This important work promises to transform glaucoma care and preserve vision for countless patients worldwide. Learn more at glaucoma.org/catalyst Visit glaucoma.org/grants to learn more about our 2015 research grants.. 3 4 Adrienne L. Graves, PhD Independent Director San Francisco, CA Yehia Hashad, MD Allergan, Inc. Irvine, CA John Hetherington, Jr., MD University of California San Francisco, CA H. Dunbar Hoskins, Jr., MD American Academy of Ophthalmology (Retired) San Francisco, CA Linda C. Linck Delta Gamma Foundation Lafayette, CA Dennis E. Singleton Spieker Partners Menlo Park, CA Monica L. Vetter, PhD University of Utah Salt Lake City, UT Martin B. Wax, MD PanOptica, Inc. Bernardsville, NJ Ruth D. Williams, MD Wheaton Eye Clinic Wheaton, IL Charles Wilmoth Wells Fargo Advisors, LLC San Francisco, CA Founder Robert N. Shaffer, MD (1912–2007) Honorary Advisory Board F.T. Barr Afex International, Inc. Houston, TX June Behrendt Otto The Edward J. Daly Foundation San Francisco, CA Sarah Brown San Francisco, CA Robert Drabkin Los Angeles, CA Steven Kirsch San Jose, CA Roger McGuinn Windemere, FL Robert C. Nevins Lafayette, CA David E.I. Pyott Irvine, CA Cary R. Rayment Alcon, Inc. (Retired) Ft. Worth, TX Mona Zander The Mona and Ed Zander Family Foundation Carmel, CA Professional Staff Thomas M. Brunner President and CEO Catalina San Agustin Director of Operations Michelle Davidson Development Coordinator Nancy Graydon Executive Director of Development Aileen Trieu Associate Director of Development Bonnie MacLeod Development Assistant Andrew L. Jackson Director of Communications Christie D’Angelo Assistant Director, Events and Volunteer Management 13 Dear Friends, Support from you and others dedicated to our sight-saving mission made 2015 a great year for Glaucoma Research Foundation. Our commitment to a cure, research innovation, education and better treatments for glaucoma patients has never been stronger. Together we can truly make a positive difference in the lives of those living with glaucoma, by renewing our pledge to speed GRF Council A national leadership council of glaucoma specialists dedicated to improving access to educational materials for all glaucoma patients. Rohit Krishna, MD Chair, GRF Council Charles McMahon, MD (Mountain Regional Councilor) Carl Migliazzo, MD (Central Regional Councilor) GRF Councilors Stuart F. Ball, MD Robert J. Barnes, MD Michael S. Berlin, MD Steven V.L. Brown, MD, FACS Dean Carlson, MD John S. Cohen, MD (Midwest Regional Councilor) Randy Craven, MD Robert J. Derick, MD Monte Dirks, MD Amish Doshi, MD Doreen Fazio, MD Robert Feldman, MD (Southwest Regional Councilor) Gloria P. Fleming, MD David Gilbert, MD Linda Greff, MD Agnes Huang, MD Dan Jewelewicz, MD Martin B. Kaback, MD L. Jay Katz, MD (Northeast Regional Councilor) Anup Khatana, MD Douglas Kohl, MD Michael S. Korey, MD Linda Lawrence, MD Richard Lehrer, MD the cure and by helping those seeking information and resources to better understand this disease. Thank you for your ongoing partnership — we are now closer than ever to new glaucoma treatments and ultimately a cure. Thomas M. Brunner President and CEO Steve Litinsky, MD (Southeast Regional Councilor) Anne Miller, MD Kevin Miller, MD our Johann Ohly, MD David J. Palmer, MD Cindy Penzler, MD Andrew Prince, MD a future free from glaucoma. Andrew Rabinowitz, MD George Reiss, MD Keith Sanford, MD Michael Sakamoto, MD (Western Regional Councilor) Sonja W. Schluter, MD, MPH Bradley Schuster, MD (Mountain Regional Councilor) Arthur L. Schwartz, MD Gail F. Schwartz, MD VISION our FOCUS finding a cure. My Le Shaw, MD Rajesh Shetty, MD Charles Eric Shrader, MD Oluwatosin Smith, MD (Southwest Regional Councilor) Michael Stiles, MD Thomas Tayeri, MD Mark Werner, MD Ruth Williams, MD (Midwest Regional Councilor) Jeffrey Zink, MD 251 Post Street, Suite 600, San Francisco, CA 94108 – (415) 968-3162 – www.glaucoma.org 2015 ANNUAL REPORT Andrew G. Iwach, MD Chair, Board of Directors
